LIFEVANTAGE CORP (LFVN) Fundamental Analysis & Valuation

NASDAQ:LFVN • US53222K2050

5.28 USD
+0.08 (+1.54%)
At close: Mar 11, 2026
5.28 USD
0 (0%)
After Hours: 3/11/2026, 8:08:24 PM

This LFVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to LFVN. LFVN was compared to 37 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making LFVN a very profitable company, without any liquidiy or solvency issues. LFVN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. LFVN Profitability Analysis

1.1 Basic Checks

  • LFVN had positive earnings in the past year.
  • LFVN had a positive operating cash flow in the past year.
  • Each year in the past 5 years LFVN has been profitable.
  • Each year in the past 5 years LFVN had a positive operating cash flow.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

  • The Return On Assets of LFVN (12.85%) is better than 89.19% of its industry peers.
  • LFVN has a better Return On Equity (23.83%) than 94.59% of its industry peers.
  • With an excellent Return On Invested Capital value of 15.68%, LFVN belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for LFVN is in line with the industry average of 11.32%.
  • The 3 year average ROIC (11.79%) for LFVN is below the current ROIC(15.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.85%
ROE 23.83%
ROIC 15.68%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.74%, LFVN is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
  • In the last couple of years the Profit Margin of LFVN has declined.
  • LFVN has a Operating Margin of 4.26%. This is comparable to the rest of the industry: LFVN outperforms 54.05% of its industry peers.
  • LFVN's Operating Margin has declined in the last couple of years.
  • LFVN has a better Gross Margin (78.75%) than 91.89% of its industry peers.
  • In the last couple of years the Gross Margin of LFVN has remained more or less at the same level.
Industry RankSector Rank
OM 4.26%
PM (TTM) 3.74%
GM 78.75%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. LFVN Health Analysis

2.1 Basic Checks

  • LFVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, LFVN has less shares outstanding
  • The number of shares outstanding for LFVN has been reduced compared to 5 years ago.
  • LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • LFVN has an Altman-Z score of 3.35. This indicates that LFVN is financially healthy and has little risk of bankruptcy at the moment.
  • LFVN has a Altman-Z score of 3.35. This is in the better half of the industry: LFVN outperforms 70.27% of its industry peers.
  • LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.35
ROIC/WACC1.78
WACC8.79%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.3 Liquidity

  • LFVN has a Current Ratio of 2.03. This indicates that LFVN is financially healthy and has no problem in meeting its short term obligations.
  • LFVN has a Current ratio of 2.03. This is comparable to the rest of the industry: LFVN outperforms 43.24% of its industry peers.
  • A Quick Ratio of 1.03 indicates that LFVN should not have too much problems paying its short term obligations.
  • The Quick ratio of LFVN (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.03
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

0

3. LFVN Growth Analysis

3.1 Past

  • LFVN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.78%.
  • The Earnings Per Share has been decreasing by -1.70% on average over the past years.
  • The Revenue has decreased by -0.99% in the past year.
  • LFVN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.38% yearly.
EPS 1Y (TTM)2.78%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%-31.82%
Revenue 1Y (TTM)-0.99%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%-27.79%

3.2 Future

  • The Earnings Per Share is expected to decrease by -6.75% on average over the next years.
  • The Revenue is expected to decrease by -10.05% on average over the next years. This is quite bad
EPS Next Y-11.95%
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%
EPS Next 5YN/A
Revenue Next Year-16.27%
Revenue Next 2Y-8.93%
Revenue Next 3Y-10.05%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

6

4. LFVN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.14 indicates a rather cheap valuation of LFVN.
  • 91.89% of the companies in the same industry are more expensive than LFVN, based on the Price/Earnings ratio.
  • LFVN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
  • The Price/Forward Earnings ratio is 8.44, which indicates a very decent valuation of LFVN.
  • LFVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LFVN is cheaper than 83.78% of the companies in the same industry.
  • LFVN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.14
Fwd PE 8.44
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 94.59% of the companies in the same industry are more expensive than LFVN, based on the Enterprise Value to EBITDA ratio.
  • LFVN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 39.84
EV/EBITDA 4.74
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The decent profitability rating of LFVN may justify a higher PE ratio.
  • LFVN's earnings are expected to decrease with -6.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%

5

5. LFVN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.83%, LFVN has a reasonable but not impressive dividend return.
  • LFVN's Dividend Yield is rather good when compared to the industry average which is at 1.66. LFVN pays more dividend than 86.49% of the companies in the same industry.
  • LFVN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.83%

5.2 History

  • LFVN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 28.13% of the earnings are spent on dividend by LFVN. This is a low number and sustainable payout ratio.
DP28.13%
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LFVN Fundamentals: All Metrics, Ratios and Statistics

LIFEVANTAGE CORP

NASDAQ:LFVN (3/11/2026, 8:08:24 PM)

After market: 5.28 0 (0%)

5.28

+0.08 (+1.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-04
Earnings (Next)05-04
Inst Owners65.99%
Inst Owner Change4.08%
Ins Owners9.2%
Ins Owner Change1.73%
Market Cap67.53M
Revenue(TTM)210.05M
Net Income(TTM)7.86M
Analysts82.5
Price Target8.16 (54.55%)
Short Float %34.75%
Short Ratio15.71
Dividend
Industry RankSector Rank
Dividend Yield 3.83%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP28.13%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-02
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.29%
Min EPS beat(2)-4.61%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)11.09%
Min EPS beat(4)-5.12%
Max EPS beat(4)56.07%
EPS beat(8)3
Avg EPS beat(8)12.28%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.32%
Min Revenue beat(2)-14.83%
Max Revenue beat(2)-11.8%
Revenue beat(4)0
Avg Revenue beat(4)-9.43%
Min Revenue beat(4)-14.83%
Max Revenue beat(4)-5.04%
Revenue beat(8)0
Avg Revenue beat(8)-7.68%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-44.83%
PT rev (3m)-44.83%
EPS NQ rev (1m)-59.48%
EPS NQ rev (3m)-59.48%
EPS NY rev (1m)-35.67%
EPS NY rev (3m)-35.67%
Revenue NQ rev (1m)-24.3%
Revenue NQ rev (3m)-24.3%
Revenue NY rev (1m)-15.24%
Revenue NY rev (3m)-15.24%
Valuation
Industry RankSector Rank
PE 7.14
Fwd PE 8.44
P/S 0.32
P/FCF 39.84
P/OCF 18.02
P/B 2.05
P/tB 2.31
EV/EBITDA 4.74
EPS(TTM)0.74
EY14.02%
EPS(NY)0.63
Fwd EY11.85%
FCF(TTM)0.13
FCFY2.51%
OCF(TTM)0.29
OCFY5.55%
SpS16.42
BVpS2.58
TBVpS2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.55
Profitability
Industry RankSector Rank
ROA 12.85%
ROE 23.83%
ROCE 21.24%
ROIC 15.68%
ROICexc 20.67%
ROICexgc 23.45%
OM 4.26%
PM (TTM) 3.74%
GM 78.75%
FCFM 0.81%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
ROICexc(3y)21.53%
ROICexc(5y)26%
ROICexgc(3y)21.81%
ROICexgc(5y)26.49%
ROCE(3y)15.97%
ROCE(5y)19.54%
ROICexgc growth 3Y16.93%
ROICexgc growth 5Y-18.84%
ROICexc growth 3Y17.48%
ROICexc growth 5Y-17.77%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
F-Score7
Asset Turnover3.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 70.43%
Cap/Sales 0.98%
Interest Coverage 995.11
Cash Conversion 31.57%
Profit Quality 21.56%
Current Ratio 2.03
Quick Ratio 1.03
Altman-Z 3.35
F-Score7
WACC8.79%
ROIC/WACC1.78
Cap/Depr(3y)63.96%
Cap/Depr(5y)69.38%
Cap/Sales(3y)1.05%
Cap/Sales(5y)1.12%
Profit Quality(3y)198.8%
Profit Quality(5y)180.19%
High Growth Momentum
Growth
EPS 1Y (TTM)2.78%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%-31.82%
EPS Next Y-11.95%
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.99%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%-27.79%
Revenue Next Year-16.27%
Revenue Next 2Y-8.93%
Revenue Next 3Y-10.05%
Revenue Next 5YN/A
EBIT growth 1Y-17.4%
EBIT growth 3Y17.09%
EBIT growth 5Y-4.68%
EBIT Next Year24.45%
EBIT Next 3Y-4.59%
EBIT Next 5YN/A
FCF growth 1Y-83.93%
FCF growth 3Y17.78%
FCF growth 5Y-7.66%
OCF growth 1Y-72.71%
OCF growth 3Y14.27%
OCF growth 5Y-8.31%

LIFEVANTAGE CORP / LFVN FAQ

What is the fundamental rating for LFVN stock?

ChartMill assigns a fundamental rating of 6 / 10 to LFVN.


What is the valuation status for LFVN stock?

ChartMill assigns a valuation rating of 6 / 10 to LIFEVANTAGE CORP (LFVN). This can be considered as Fairly Valued.


What is the profitability of LFVN stock?

LIFEVANTAGE CORP (LFVN) has a profitability rating of 7 / 10.


What is the financial health of LIFEVANTAGE CORP (LFVN) stock?

The financial health rating of LIFEVANTAGE CORP (LFVN) is 8 / 10.


Can you provide the expected EPS growth for LFVN stock?

The Earnings per Share (EPS) of LIFEVANTAGE CORP (LFVN) is expected to decline by -11.95% in the next year.